Maxcyte (MXCT) Enterprise Value Growth (1y) (2021 - 2026)
Maxcyte (MXCT) Enterprise Value Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn |
| 10 | Maxcyte | 147.95 Mn | 147.95 Mn | 5.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.49% |
| Mar 31, 2026 | 22.72% |
| Dec 31, 2025 | 33.30% |
| Sep 30, 2025 | 31.27% |
| Jun 30, 2025 | 19.56% |
| Mar 31, 2025 | 12.22% |
| Dec 31, 2024 | 8.20% |
| Sep 30, 2024 | 19.14% |
| Jun 30, 2024 | 27.20% |
| Mar 31, 2024 | 29.89% |
| Dec 31, 2023 | 25.98% |
| Sep 30, 2023 | 18.31% |
| Jun 30, 2023 | 10.29% |
| Mar 31, 2023 | 8.78% |
| Dec 31, 2022 | 10.86% |
| Sep 30, 2022 | 8.99% |
| Jun 30, 2022 | -228.22% |
| Dec 31, 2021 | -633.67% |